Gary Zenker’s Post

#AI dominated discussions at #JPM2024 with the potentially transformative impact it can have on #biopharma. There's also been a noticeable air of cautious optimism at #JPM24 that could carry over this year in terms of #MandA, #funding and the #IPO market. https://lnkd.in/gPERD5Su #artificialintelligence #venturecapital #biotech #pharma BioSpace

In a recent webinar "De-risking Innovation in Small Pharma and Biotech Clinical Research – Possible or Not?", we discussed what innovation looked like for smaller pharma and laid out the drivers and variables that influenced their work. Our panelist Erin O'Boyle highlighted that protocol compliance is one of the most important aspects of a study. But, complex studies are a significant burden on both sites and patients, leading to compliance issues. Simplifying these studies is essential to ensure smooth operations and successful outcomes. By simplifying the complex, you can better support your sites, improve patient experience, and enhance overall study compliance. Erin, thank you for being part of our conversation! A protocol automation platform can eliminate site burden through real-time guidance, task automation, and technology orchestration. Learn more: https://bit.ly/4aPS9wc. Watch webinar recording 👉🏽 https://bit.ly/4c2NBUg #ClinicalResearch #ClinicalInnovation #ClinicalTrials #pharmawebinar #biotechwebinar

“Using adaptive clin­ical trial designs in early development can help rapidly advance a fit-for-phase for­mulation to a POC-ready format, optimize performance of a drug product in re­sponse to emerging clinical data, and gain valuable data to inform the next stage of development.” Read the full article to understand the benefits #TranslationalPharmaceutics could have on your clinical development projects. #QuotientSciences

🔬With over 3,000 experts in attendance, including big pharma giants like Pfizer, Novartis, and Merck, Cambridge Healthtech Institute’s Bio-IT World Conference & Expo was a powerhouse of insights. Learn about cutting-edge developments in #GenAI and real-world data platforms: https://ow.ly/reUR50RqV0W Discover how organizations are leveraging #AI to transform drug discovery and patient care while navigating challenges and seizing opportunities in the evolving landscape. #BioITWorld #LifeSciences #Innovation #Technology

Thank you, Nimita Limaye, for providing additional thoughts and research-based insights on this year's Bio-IT World Conference & Expo and the concurrent Bio-IT World: Venture, Innovation & Partnering Conference. IDC's findings on the speed of #AI adoption, matching the main conference's AI focus, are especially striking. More below!

In this feature with Drug Development & Delivery, Andy Lewis, Chief Scientific Officer, speaks on our #TranslationalPharmaceutics® platform and its benefits to accelerating and controlling the full #drugdevelopment value chain, including implementing adaptive clinical trial designs and transforming the traditional model. Read the full article here: https://bit.ly/4bqABaj

How do we break through the barriers to expand real-world data use across pharma? ➡ Life science companies are engaged in a never-ending quest to get more effective, safer therapies to patients in a faster and more accessible manner.  ➡ But there are still unexplored areas of opportunity for strengthening – and shortening – the R&D pipeline.  And real-world data is at the top of that list. ➡ While the use of real-world data in clinical trials has increased since the pandemic, we’re still extracting only a fraction of the benefit that rich, curated, multi-modal, real-world information can provide to us. ➡ So the question remains, why aren’t more pharma companies using real-world data as a core component of research and development, especially when evidence is piling up that it can change the way we view drug development and precision medicine? 🔽 Read more on our blog 🔽 link in comments 🔽 #rwd #realworlddata #pharma #oncologyresearch #clinicaltrials

Are you in a rut on where to infuse innovation in your company? Is innovation in clinical operations only for big pharma, with their seemingly endless budgets and resources? What about biotech? Are they confined to molecule development, missing out on innovation opportunities? In my journey, I've learned that embracing change is crucial for staying ahead. That's why I'm excited to extend this invitation to you for our upcoming webinar on Monday, May 20th at 12pm EST where leading experts in small/midsize pharma will dive into actionable insights and strategies for integrating innovation into such organizations. 💡🚀 Trust me, you don't want to miss this amazing lineup featuring: Erin O'Boyle, Joseph K., Lauren Briggs, Erika Talbott, Joann Peters & Meraf Eyassu 🌟 We will discuss: 🔹 Challenges faced by biotech development groups in clinical research. 🔹 Pearls of wisdom from seasoned professionals in biotech and mid-pharma. 🔹 Winning strategies and crucial drivers in biotech drug development. 🔹 The essential role of innovation in overcoming biotech limitations. Secure your spot NOW! 🔬➡️ https://lnkd.in/g6TffZfp #clinicaloperations #clinicalinnovation #clinicalresearch #clinicaltrials #innovation #webinar

We look back on our journey—to the launch of our sophisticated workflow management tool in collaboration with AstraZeneca, which was revealed at SLAS Boston a few months back. Our partnership represents a shared vision of utilising technology to achieve significant advancements in drug discovery. The tool, powered by our cutting-edge iTraX™ technology, is a game-changer in managing intricate workflows and extensive datasets, accelerating the path from groundbreaking science to life-saving treatments. Key Features of iTraX™ 🔹It's intuitively designed to support and scale with various research projects, exemplifying flexibility in the rapidly evolving scientific landscape. 🔹It underscores the triumphs possible when industry leaders come together for a  common purpose. 🔹With our sights set on constant evolution, we are excited to reveal ongoing refinements at the forthcoming Lab of the Future conference. It's more than a tool. It's our commitment to streamlining complex processes for scientists worldwide, aiding them in their quest to deliver timely health solutions. 🔗 Gain deeper insights here: https://lnkd.in/e_65b4Bz #ElixirSoftware #AstraZeneca #Workflow #DrugDiscovery #Innovation

I wanted to share an update about a recent report we have published - Where pharma is Investing for the Future of Medicine. This report shares an insight into actual developments in terms of technologies, geographies and opportunities. https://lnkd.in/dwDDtxDW